Neuropathological criteria of anti-IgLON5-related tauopathy

Acta Neuropathologica

Volumn 132, Issue 4, 2016, Pages 531-543

  Gelpi, Ellen ^a   Höftberger, Romana ^b,c   Graus, Francesc ^a,c   Ling, Helen ^d   Holton, Janice L ^d   Dawson, Timothy ^e   Popovic, Mara ^f   Pretnar Oblak, Janja ^g   Högl, Birgit ^h   Schmutzhard, Erich ^h   Poewe, Werner ^h   Ricken, Gerda ^b   Santamaria, Joan ^a   Dalmau, Josep ^c,i,j   Budka, Herbert ^k   Revesz, Tamas ^d   Kovacs, Gabor G ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF LJUBLJANA   (Slovenia)

^g UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^h INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^k UNIVERSITY HOSPITAL ZURICH   (Switzerland)

more..

Author keywords

Brainstem; IgLON5; NREM; Parasomnia; Tauopathy

Indexed keywords

HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; IGLON5 PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN ANTIBODY; TAU PROTEIN; UNCLASSIFIED DRUG; IGLON5 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BRAIN STEM; BULBAR PARALYSIS; CEREBROSPINAL FLUID LEVEL; CERVICAL SPINAL CORD; CLINICAL ARTICLE; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; MALE; MIDDLE AGED; NEUROPATHOLOGY; NONREM SLEEP; PARASOMNIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REM SLEEP; SLEEP DISORDERED BREATHING; STRIDOR; TAUOPATHY; TEGMENTUM; BRAIN; IMMUNOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; TAUOPATHIES;

AGED; BRAIN; CELL ADHESION MOLECULES, NEURONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; TAU PROTEINS; TAUOPATHIES;

EID: 84976408166     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-016-1591-8     Document Type: Article

References (18)

1. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969
2. Brüggemann N, Wandinger KP, Gaig C, Stöcker W, Junghanns K, Helmchen C et al (2016) Dystonia, lower limb stiffness and upward gaze palsy in a patient with IgLON5 antibodies. Mov Disord 31:762–764
3. Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755–766
4. Dickson DW, Hauw JJ, Agid Y, Litvan I (2011) Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Wiley–Blackwell Publishers, New York, pp 135–155
5. Dutschmann M, Menuet C, Stettner GM, Gestreau C, Borghgraef P, Devijver H et al (2010) Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. J Neurosci 30:1810–1821
6. Hashimoto T, Yamada M, Maekawa S, Nakashima T, Miyata S (2008) IgLON cell adhesion molecule Kilon is a crucial modulator for synapse number in hippocampal neurons. Brain Res 1224:1–11
7. Högl B, Heidbreder A, Santamaria J, Graus F, Poewe W (2015) IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet 385:1590
8. Holton JL, Lees AJ, Revesz T (2011) Multiple system atrophy. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Wiley–Blackwell Publishers, New York, pp 242–252
9. Ishizawa T, Ko LW, Cookson N, Davias P, Espinoza M, Dickson DW (2002) Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathies. Neuropathol Exp Neurol 61:1040–1047
10. Kaphan E, Pellissier JF, Rey M, Robert D, Auphan M, Ali Chérif A (2008) Esophageal achalasia, sleep disorders and chorea in a tauopathy without ophthalmoplegia, parkinsonian syndrome, nor dementia (progressive supranuclear palsy?): clinicopathological study. Rev Neurol (Paris) 164:377–383
11. Kovacs GG (2015) Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41:3–23
12. Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87–102
13. Lidov HG, Duchen LW, Thomas PK, Thrush DC (1989) Progressive medullary failure associated with neurofibrillary degeneration. J Neurol Neurosurg Psychiatry 52:643–647
14. Montojo MT, Piren V, Benkhadra F, Codreanu A, Wirtz G, Kerschen P et al (2015) Mimicking progressive supranuclear palsy and causing Tako-Tsubo syndrome: a case report on IgLON5 encephalopathy [abstract]. Mov Disord 30(Suppl 1):710
15. Pretnar-Oblak J, Zaletel M, Hajnsek TM, Meglic B, Hocevar-Boltezar I, Popovic M (2010) Isolated bulbar paralysis in a patient with medullar tau pathology: a case report. J Neurol Neurosurg Psychiatry 81:847–849
16. Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575–586
17. Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH et al (2015) Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm 2:e136
18. Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ et al (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain 130:1566–1576